Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Direxion Daily LLY Bull 2X Shares
(NQ:
ELIL
)
19.20
+0.20 (+1.05%)
Official Closing Price
Updated: 4:15 PM EDT, Oct 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
65,119
Open
18.73
Bid (Size)
19.08 (1)
Ask (Size)
19.25 (1)
Prev. Close
19.00
Today's Range
18.73 - 19.59
52wk Range
11.50 - 26.77
Shares Outstanding
N/A
Dividend Yield
0.96%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
October 13, 2025
Via
Benzinga
Direxion's Eli Lilly-Focused Bull And Bear Funds Offer Speculative Alternatives
April 23, 2025
Via
Benzinga
Performance
YTD
-18.3%
-18.3%
1 Month
+19.2%
+19.2%
3 Month
-3.3%
-3.3%
6 Month
-21.4%
-21.4%
1 Year
-18.3%
-18.3%
Frequently Asked Questions
Is Direxion Daily LLY Bull 2X Shares publicly traded?
Yes, Direxion Daily LLY Bull 2X Shares is publicly traded.
What exchange does Direxion Daily LLY Bull 2X Shares trade on?
Direxion Daily LLY Bull 2X Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Direxion Daily LLY Bull 2X Shares?
The ticker symbol for Direxion Daily LLY Bull 2X Shares is ELIL on the Nasdaq Stock Market
What is the current price of Direxion Daily LLY Bull 2X Shares?
The current price of Direxion Daily LLY Bull 2X Shares is 19.20
When was Direxion Daily LLY Bull 2X Shares last traded?
The last trade of Direxion Daily LLY Bull 2X Shares was at 10/24/25 04:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.